Updated Jul 16, 2026
Odysseas Kostas D has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
Odysseas Kostas D is a director at Armata Pharmaceuticals, Inc., a biotechnology company focused on developing therapies for antibiotic-resistant infections. Specific details about his background, education, and previous roles are not widely available in public records.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-21 | AMRN | AMARIN CORP PLC\UK | F — Tax withholding / forfeiture | 403 | $14.98 | $6K |
| 2026-04-21 | AMRN | AMARIN CORP PLC\UK | M — Option exercise | 838 | — |
Odysseas Kostas D is a director at Armata Pharmaceuticals, Inc., a biotechnology company focused on developing therapies for antibiotic-resistant infections. Specific details about his background, education, and previous roles are not widely available in public records.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Odysseas Kostas D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.